Guidance Provided for Fecal Microbiota Transplantation in Children
By Elana Gotkine HealthDay Reporter
MONDAY, Nov. 20, 2023 -- For pediatric patients, fecal microbiota transplantation (FMT) is recommended for moderate-to-severe or recurrent Clostridioides difficile infection (CDI), according to a clinical report published online Nov. 20 in Pediatrics.
Noting that current evidence supports the use of FMT for treatment of CDI in adults, Maria Oliva-Hemker, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues provided an overview of the use of FMT for children to facilitate appropriate guidance for families interested in FMT treatment.
The authors note there are no prospective clinical trials in children using FMT for CDI treatment. However, for pediatric patients with moderate-to-severe or recurrent CDI, studies support FMT use. To date, FMT is not recommended for clinical treatment of other medical conditions. For safety reasons, do-it-yourself, at-home FMT should not be performed in children. FMT should be performed in a center with adequate experience with the procedure. Regulatory standards are lacking for fecal preparations for FMT. The long-term effects of FMT are currently unknown. Rapid advances are anticipated in the field of antimicrobial therapies, which will potentially bring commercial products for the treatment of CDI.
"Although the anticipated benefit of these commercial microbiota therapeutics is appealing, they will likely come with their own set of challenges for children," the authors write. "It is also important to advocate that clinical trials for microbial therapeutic products include pediatric populations."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Reduced Vancomycin Susceptibility Tied to Poorer C. Diff Outcomes
TUESDAY, April 30, 2024 -- Reduced vancomycin susceptibility is impacting clinical responses among adults with Clostridioides difficile (C. difficile) infection, according to a...
AGA Recommends Fecal Microbiota Transplant for Recurrent C. Difficile
MONDAY, Feb. 26, 2024 -- Fecal microbiota transplant is recommended on completion of standard-of-care antibiotics to prevent recurrence for adults with recurrent Clostridioides...
Ingestion Hazard Prompts Recall of Small Magnetic Balls
FRIDAY, Dec. 29, 2023 -- Citing thousands of hospitalizations and at least seven deaths linked to high-powered magnetic balls, the U.S. Consumer Product Safety Commission...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.